1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Fluid Overload: new trials by email Literature Review of Fluid Overload trials Research Report on Fluid Overload
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure Extended Release Torsemide Tablets, Immedate Release Torsemide Tablets - Heart Failure, Edema | Phase 4 | Withdrawn | Sarfez Pharmaceuticals, Inc. | 2025-05-01 | 2026-09-28 |
Edema (1) · Heart Failure (1) · Hypernatremia (1) · Renal Insufficiency, Chronic (1)
Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Signs and Symptoms (1) · Urogenital Diseases (1)
Sarfez Pharmaceuticals, Inc. (1)
United States (1)